Average Co-Inventor Count = 7.56
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Smithkline Beecham Corporation (14 from 2,198 patents)
2. Glaxosmithkline Intellectual Property Development Limited (7 from 230 patents)
3. Glaxosmithkline LLC (3 from 356 patents)
4. Glaxo Wellcome Inc. (2 from 281 patents)
26 patents:
1. 11485710 - Heterocyclic amides as kinase inhibitors
2. 10940154 - Heterocyclic amides as kinase inhibitors
3. 10933070 - Heterocyclic amides as kinase inhibitors
4. 10899716 - Heterocyclic amides as kinase inhibitors
5. 10590085 - Heterocyclic amides as kinase inhibitors
6. 10292987 - Heterocyclic amides as kinase inhibitors
7. 9556152 - Heterocyclic amides as kinase inhibitors
8. 8114885 - Chemical compounds
9. 7858626 - Pyrimidineamines as angiogenesis modulators
10. 7812022 - 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors
11. 7279473 - Pyrazolopyridazine derivatives
12. 7262203 - Pyrimidineamines as angiogenesis modulators
13. 7238813 - Chemical compounds
14. 7189712 - 1,3-Oxazole compounds for the treatment of cancer
15. 7163940 - Pyrazolopyridinyl pyrimidine therapeutic compounds